Clinical and laboratory findings in referrals for mitochondrial DNA analysis

Archives of Disease in Childhood

Volumn 79, Issue 1, 1998, Pages 22-27

  Lamont, P J ^a   Surtees, R ^b   Woodward, C E ^a   Leonard, J V ^b   Wood, N W ^a   Harding, A E ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Leigh's syndrome; Mitochondrial cytopathy; Mitochondrial DNA mutation; Severe infantile lactic acidosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA DETERMINATION; EXTERNAL OPHTHALMOPLEGIA; HISTOCHEMISTRY; HUMAN; LACTIC ACIDOSIS; LEIGH DISEASE; MAJOR CLINICAL STUDY; MYOPATHY; NUCLEOTIDE SEQUENCE; PATIENT REFERRAL; POINT MUTATION; PRIORITY JOURNAL; RETINOPATHY;

EID: 0031824802     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.79.1.22     Document Type: Article

References (30)

1. Tatuch Y, Christodoulou J, Feigenbaum A, et al. Heteroplasmic mtDNA mutation (T-G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high. Am J Hum Genet 1992;50:852-8.
2. Shoffner J, Lott M, Lezza A, Seibel P, Ballinger S, Wallace D. Myoclonic epilepsy and ragged red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA-Lys mutation. Cell 1990;61:931-7.
3. Sweeney M, Hammans S, Duchen L, et al. Mitochondrial DNA mutation underlying Leigh's syndrome: clinical, pathological, biochemical, and genetic studies of a patient presenting with progressive myoclonic epilepsy. J Neurol Sci 1994;121:57-65.
4. Ionasescu V, Hart M, DiMauro S, Moraes C. Clinical and morphological features of a myopathy associated with a point mutation in the mitochondrial tRNAPro gene. Neurology 1994;44:975-7.
5. Yoon K, Aprille J, Ernst S. Mitochondrial tRNAthr mutation in fatal infantile respiratory enzyme deficiency. Biochem Biophys Res Common 1991;176:1112-15.
6. Jackson M, Schaefer J, Johnson M, Morris A, Turnbull , Bindoff L. Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain 1995;118:339-57.
7. Holt I, Harding A, Petty R, Morgan-Hughes J. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990;46:428-33.
8. Holt I, Harding A, Morgan-Hughes J. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988;331:717-19.
9. Berkovic S, Carpenter S, Evans A, et al. Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 1989;112: 1231-60.
10. Rotig A, Colonna M, Bonnefont J, et al. Mitochondrial DNA deletion in Pearson's marrow pancreas syndrome. Lancet 1989;i:902-3.
11. Berenberg R, Pellock J, DiMauro S. Lumping or splitting? "Ophthalmoplegia-plus" or Kearns-Sayre syndrome? Ann Neurol 1977;1:37-54.
12. Davis P, Hoffman J Jr, Braun I, Ahmann P, Krawiecki N. MR of Leigh's disease (subacute necrotizing encephalomyelopathy). Am J Neuroradiol 1987;8:71-5.
13. Geyer C, Sartor R, Prensky A, Abramson C, Hodges F, Gado M. Leigh disease (subacute necrotizing encephalomyelopathy): CT and MR in five cases. J Comp Assist Tomog 1988;12:40-4.
14. Pincus J. Subacute necrotizing encophalomyelopathy (Leigh's disease): a consideration of clinical features and etiology. Dev Med Child Neurol 1972;14:87-101.
15. de Vries D, van Engelen B, Gabreels F, Ruitenbeck W, van Oost B. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann Neurol 1993;34: 410-12.
16. Yamamoto M, Clemens P, Engel A. Mitochondrial DNA deletions in mitochondrial cytopathies: observations in 19 patients. Neurology 1991;41:1822-8.
17. Aicardi J. Diseases of the nervous system in childhood. London: MacKeith Press, 1902:1408.
18. Anon. Mitochondrial encephalomyopathies: gene mutation. Neuromuscular Disord 1995;5:v-vi.
19. Shoffner J, Fernhoff P, Krawiecki N. Subacute necrotizing encephalopathy: oxidative phosphorylation defects and the ATPase 6 point mutation. Neurology 1992;42:2168-74.
20. Ciafaloni E, Santorelli F, Shanske S. Maternally inherited Leigh's syndrome. J Pediatr 1993;122:419-22.
21. Somer H, Suomalainen A, Haltia M, Peltonen L. Deletion of mitochondrial DNA in the adult form of Leigh's syndrome. Neurology 1991;41(suppl 1):208.
22. Santorelli F, Shanske S, Macaya A, DeVivo D, DiMauro S. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol 1993;34:827-34.
23. Hammans S, Sweeney M, Brockington M, Morgan-Hughes J, Harding A. Mitochondrial encephalopathies: molecular genetic diagnosis from blood samples. Lancet 1991;337: 1311-13.
24. Zeviani M, Gellera C, Pannacci M, et al. Tissue distribution and transmission of mitochondrial DNA deletions in mitochondrial myopathies. Ann Neurol 1990;28:94-7.
25. Byrne E, Trounce I, Dennett X. Progression from MERRF to MELAS phenotype in a patient with combined respiratory complex I and IV deficiencies. J Neurol Sci 1988;88:327-38.
26. Hammans S, Morgan-Hughes J. Mitochondrial myopathies: clinical features, investigation, treatment and genetic counselling. Mitochondrial Disorders in Neurology 1994;1:49-74.
27. Holt I, Harding A, Cooper J, et al. Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 1989;26:699-708.
28. Petty R, Harding A, Morgan-Hughes J. The clinical features of mitochondrial myopathy. Brain 1986;109:915-38.
29. Morris A, Lamont P, Clayton P. Pearson's syndrome without marrow involvement. Arch Dis Child 1997;77:56-7.
30. Zeviani M, Servidei S, Gellera C, Bertini E, DiMauro S, DiDonato S. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989;339:309-11.